Vaccine strains for the 2023–24 influenza vaccines were selected by the Food and Drug Administration’s Vaccines and Related Biologic Products Advisory Committee based on WHO’s recommended Northern Hemisphere 2023–24 influenza vaccine composition.
Blog Entry List
This bulletin replaces NC Medicaid Temporary Flexibilities Due to Hurricane Idalia published on Aug. 30, 2023, to correct the end date.
Provider guidance for reimbursement, enrollment and providing care for Medicaid beneficiaries
Clinical Coverage Pharmacy Policy 9 will allow for donation of abandoned Long-Acting Injectable Antipsychotics to a registered Drug Repository Program
Effective with date of service, March 6, 2023, Medicaid and NC Health Choice cover flortaucipir F 18 injection.
On/Go COVID-19 HOME COLLECT KIT added to coverage.
Lantus® SoloStar® / Vial will move to preferred on the NC Medicaid Preferred Drug List, effective March 24, 2023.
As of April 1, 2023, all NC Health Choice beneficiaries with active eligibility will be moved to Medicaid.
Tobacco-related policy requirements go into effect on April 1, 2024.
PIXEL COVID-19 Home Collection Kit Change
Note: This bulletin is replaced by NC Health Choice Move to Medicaid: Timeline for Claims Adjudication and Process for Prior Approvals.
Includes Pharmacy Point of Sale, Physician Administered Drug Program and Outpatient Hospital Pharmacy
The insulin glargine vial and insulin glargine Solostar® will be added as Preferred on the NC Medicaid Preferred Drug List, effective Jan. 27, 2023.
Point-of-sale (POS) billing for FDA-authorized over-the-counter (OTC) COVID-19 tests dispensed for use by NC Medicaid beneficiaries in a home setting remains in effect for NC Medicaid Direct and all five managed care plans.
Vaccine Immunization Claims Can Be Submitted on Pharmacy Claims for NC Medicaid Direct Beneficiaries
Effective Dec. 1, 2022, pharmacy providers who administer immunizations at pharmacies may bill NC Medicaid Direct for vaccines on pharmacy claims